Draft:SAPIO Sciences

SAPIO Sciences is a technology company that develops software to support drug research and discovery processes. Founded by Kevin Cramer, SAPIO Sciences has developed software products for laboratory operations, particularly in biotechnology and chemistry.

History
SAPIO Sciences was established in 2007 in West Manchester by Kevin Cramer and moved to in York, Pennsylvania in 2015. Kevin Cramer has a background in Information Systems from York College, PA. He has co-authored multiple papers in Nature Genetics, applying statistical and machine learning methodologies to genetic data interpretation.

SAPIO Sciences introduced its first product, Exemplar LIMS 1.0. In 2013, Sapio Sciences launched Web Client 1.0. Sapio was then the first to integrate a full-featured, web-based Electronic Lab Notebook with its LIMS (Laboratory Information Management System) built together on a single software platform in 2017.

In 2020 the company launched a new Sapio Platform that extended its core platform with additional modules for data analysis and knowledge extraction. The Sapio Platform was iterated on to add templated modules for different life sciences applications, including biotechnology research, next-generation sequencing (NGS), bioanalysis, etc.

In 2021, IQVIA and SAPIO Sciences collaborated to provide a Laboratory System to the National Genome Center in Denmark.

In November 2022, SAPIO Sciences was fully acquired by GHO Capital Partners LLP, a specialist life sciences investment company based in London.

In 2023, the company launched SAPIO Chemistry, which unifies small-molecule and large-molecule discovery workflows on a single laboratory platform.

In the summer of 2023, NatureMetrics selected Sapio LIMS to enable environmental DNA sequencing. In 2023, Oxford Biomedica selected Sapio ELN for its cell and gene therapy research and development business. In 2023, Immunebridge announced it had selected the Sapio Electronic Lab Notebook to modernize its enterprise data management for its work on NK cell-based immunotherapies. In November 2023, Sapio Sciences became the first company to introduce an AI-Chat Scientific Assistant integrated directly into an Electronic Laboratory Notebook (ELN), called ELaiN (Electronic Lab Artificially Intelligent Notebook).

Operations
SAPIO Sciences is focused on expediting drug discovery processes through its unified lab platform that has built-in science applications and data management tools, including web client, data designer, and a workflow engine, among other tools. Kevin Cramer is the founder and CEO.

The company is headquartered in York, PA and has offices in Fort Lauderdale, FL, London, United Kingdom, and Seoul, South Korea.

Company's key products, formerly known as Exemplar, include: Sapio Platform, Sapio LIMS, Sapio ELN, Sapio Jarvis, and Sapio ELaiN.